Sebaceous neoplasms in Lynch syndrome by Dandapani, Monica et al.
POSTER PRESENTATION Open Access
Sebaceous neoplasms in Lynch syndrome
Monica Dandapani
*, Anu Chittenden, Aaron J Stunkel, Margery Rosenblatt, Sapna Syngal, Elena M Stoffel
From 14th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer
Dallas, TX, USA. 12-13 October 2010
Background
Sebaceous neoplasms of the skin (SN) are described in
the Muir Torre variant of Lynch syndrome (LS). Guide-
lines recommend evaluating individuals diagnosed with
sebaceous adenomas or sebaceous carcinomas for LS
with immunohistochemistry (IHC) for mismatch repair
(MMR) proteins and/or microsatellite instability analysis
(MSI). The assumption has been that SNs with defective
MMR are related to LS.
Purpose
To describe outcomes of genetic testing for LS among
individuals with SN.
Results
24 individuals with a personal history of SN underwent
a genetic evaluation for Lynch syndrome (LS) at Dana-
Farber Cancer Institute. 10 had family histories which
met Amsterdam criteria, 8 had a personal history of
another LS-associated malignancy, 23 had family history
of one or more LS-associated cancers, and 1 had no
other personal or family history of cancer.
11/24 (46%) probands had pathogenic MMR gene
mutations (2 MLH1 and 9 MSH2) and each of these
either met Amsterdam criteria or had a personal history
of another LS-related cancer.
Of 13 probands without identifiable MMR mutations,
6 had SNs with normal IHC and 7 had abnormal IHC
(3 absent MSH2 and MSH6, 2 absent MLH1 and PMS2,
1a b s e n tM L H 1o n l ya n d1a b s e n tM S H 2o n l y ) .O n eo f
the probands whose SN showed absence of MSH2 and
MSH6 had a family history which met Amsterdam cri-
teria (PREMM score=33%) and the rest had PREMM
model scores <5%.
Conclusions
Although prior reports suggest that MSI/IHC can be
useful in screening patients with SNs for LS, we found
many of these tumors demonstrate features of abnormal
MMR even when family history is not suggestive of LS
and genetic testing did not reveal MMR mutation.
Further study is needed to determine whether other
somatic mechanisms may produce the MMR deficient
phenotypes seen in many SNs.
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